|
|
 |
Registry of Lobbyists - John Brenton
To find further information on a company or organization check the Registry of Joint Stock Companies
|
|
| Registration Number | Status | | | 896 | Inactive | | | Initial registration date | Last date of any changes | | 26-January-2011 | 6-October-2023 |
|
Lobbyist's Last Name
Brenton |
Lobbyist's First Name
John |
Middle Initial
|
|
Business Address of Lobbyist
115 Down River Lane |
City
Barss Corner |
Province/State
NS |
Country
CA |
Postal/Zip Code
B0R 1A0 |
Telephone
902-223-4910 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
Amgen Canada |
Registry of Joint Stock Companies Number
3069325 |
Business Address of Lobbyist's Business or Firm
6775 FINANCIAL DRIVE, SUITE 100 |
City
MISSISSAUGA |
Province/State
ON |
Country
CA |
Postal/Zip Code
L5N 0A4 |
Telephone
416-865-8153 |
Fax
416-865-7380 |
|
| Beneficiary Name |
Beneficiary Type |
|
| Amgen Inc |
Parent Company |
View
|
|
|
|
|
Description of Employer's Business:
Scientific affairs, commercial operations and administrative activities in biotechnology and pharmaceutical sector. |
| |
|
|
|
| Description |
|
| Communicating with the Government of Nova Scotia about the nature of biologic and biosimilar medicines (also known as Subsequent Entry Biologics). The goal of these communications is to promote the adoption of informed policies regarding biologic and biosimilar medicines. |
View
|
| Communicating with the Government of Nova Scotia, through consultations, on a proposal for the provinces to work collectively on the bulk purchase of pharmaceutical products. These communications will involve discussions about a proposed process—and proposed roles and responsibilities for stakeholders. |
View
|
| Communicating with the Government of Nova Scotia about legislation, regulations, guidelines and policies that affect patient access to pharmaceutical products and treatments, including legislation, regulations, guidelines and policies on pricing, reimbursement plans, distribution, drug safety and effectiveness, economic development and trade.
|
View
|
|
|
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
|
|
|
